This compound is a derivative of abiraterone acetate, specifically recognized as an impurity associated with the manufacture of the pharmaceutical active ingredient. It features a steroidal backbone with a pyridine ring and an ester functional group, and its stereochemistry is well-defined.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2484719-10-8
(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
Abiraterone related compound
17-(3-Pyridinyl)-3-propanoate-androsta-5,16-dien-3-ol
active pharmaceutical ingredient
Abiraterone Impurity 54
Reference standard for impurity testing
3-Deoxy-3-chloroabiraterone (Mixture of Diastereomers)
Abiraterone acetate impurity
Beta-Epoxyabiraterone acetate
Active pharmaceutical ingredient for cancer
Alpha-Epoxyabiraterone acetate
pharmaceutical raw material
Dantrolene sodium hemiheptahydrate
muscle relaxant active pharmaceutical ingredient
Aceglutamide
nootropic and antiulcer agent
[(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
UVIQSJCZCSLXRZ-BRSOJCHPSA-N
CC(=O)O[C@@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
—